Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natrunix + Methotrexate for Rheumatoid Arthritis
NCT06590090Phase 2Not yet recruiting
- Sponsor
- XBiotech Inc.
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of XB2001 in rheumatoid arthritis (RA), sponsored by XBiotech Inc.. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
XB2001
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06590090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590090.